DOP03 Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey on processes and outcomes

A. Walsh, C. Fidalgo, M. Adamina, M. Barreiro de Acosta, J. Burisch, D. Drobne, O. Faiz, M. Ferrante, L. Godny, M. Iacucci, S. Jäghult, S. Restellini, F. Rosini, D. Shouval, H. Yanai, G. Fiorino
{"title":"DOP03 Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey on processes and outcomes","authors":"A. Walsh, C. Fidalgo, M. Adamina, M. Barreiro de Acosta, J. Burisch, D. Drobne, O. Faiz, M. Ferrante, L. Godny, M. Iacucci, S. Jäghult, S. Restellini, F. Rosini, D. Shouval, H. Yanai, G. Fiorino","doi":"10.1093/ecco-jcc/jjad212.0043","DOIUrl":null,"url":null,"abstract":"\n \n \n The European Crohn’s and Colitis Organisation (ECCO) Position Paper on Quality-of-Care (QoC) proposed essential standards on process and outcomes for units that manage patients with inflammatory bowel disease (IBD). The E-QUALITY taskforce investigated whether gaps between these standards and real-world practice exist.\n \n \n \n A 74-question web survey accessible to all institutions affiliated with ECCO was developed. One delegate per institution was requested to respond. A descriptive analysis was done.\n \n \n \n From March to October 2023, 166 centres from 28 different countries replied to the survey (Fig.1).\n At diagnosis, disease extent is assessed by colonoscopy in 96% and completed by small bowel (SB) evaluation in 43%. At least 2 biopsies from each segment are obtained in 55%. SB investigation for Crohn’s disease (CD) takes place in 60%. 54% of centres provide access to endoscopy with deep sedation for the majority of patients. To assess treatment response, faecal calprotectin is used in 65%, endoscopy in 54%, cross-sectional imaging for CD in 36%. In the case of primary failure of any drug, therapeutic decisions are based on objective measures of inflammation in 98%. A scheduled monitoring protocol for asymptomatic patients is followed in 42%. Patients with prolonged use of corticosteroids are being switched to a steroid-sparing treatment in 84%, but there is no protocol to track or act upon high steroid exposure in 43% of centres. 72% centres monitor metabolic bone health. Only 51% of units screen IBD patients for colorectal cancer, but screening is done with high-definition endoscopy in 92%. Chromoendoscopy with targeted biopsies is performed in only 47% units. Patients with perianal fistula are managed by combined medical and surgical approach in 67%, and reassessment by clinical and endoscopy and/or pelvic MRI is done in 62%. Laparoscopic approach for intra-abdominal surgery is used in 76%, and preoperative nutritional assessment in 62%. Patients receive therapies to prevent post-operative recurrence based on risk factors in 70%, standard endoscopy within 6-12 months after surgery is done only in 52% of centres. Although only 8% of centres lack a defined protocol to manage acute severe ulcerative colitis flares, 13% lack a standard algorithm, and 36% do not involve the surgeon in this setting from day 1. 38% of centres have a paediatric to adult transition clinic.\n The main reason for not adhering to ECCO standards are difficulty of providing tests in a timely fashion in up to 83% of centres.\n \n \n \n Our survey has revealed significant gaps between ECCO standards and real-world practice. These results will help ECCO improve initiatives to help institutions to provide standard QoC.\n 1) Fiorino et al. JCC 2020;14:1037-48\n \n","PeriodicalId":15453,"journal":{"name":"Journal of Crohn's and Colitis","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Crohn's and Colitis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ecco-jcc/jjad212.0043","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The European Crohn’s and Colitis Organisation (ECCO) Position Paper on Quality-of-Care (QoC) proposed essential standards on process and outcomes for units that manage patients with inflammatory bowel disease (IBD). The E-QUALITY taskforce investigated whether gaps between these standards and real-world practice exist. A 74-question web survey accessible to all institutions affiliated with ECCO was developed. One delegate per institution was requested to respond. A descriptive analysis was done. From March to October 2023, 166 centres from 28 different countries replied to the survey (Fig.1). At diagnosis, disease extent is assessed by colonoscopy in 96% and completed by small bowel (SB) evaluation in 43%. At least 2 biopsies from each segment are obtained in 55%. SB investigation for Crohn’s disease (CD) takes place in 60%. 54% of centres provide access to endoscopy with deep sedation for the majority of patients. To assess treatment response, faecal calprotectin is used in 65%, endoscopy in 54%, cross-sectional imaging for CD in 36%. In the case of primary failure of any drug, therapeutic decisions are based on objective measures of inflammation in 98%. A scheduled monitoring protocol for asymptomatic patients is followed in 42%. Patients with prolonged use of corticosteroids are being switched to a steroid-sparing treatment in 84%, but there is no protocol to track or act upon high steroid exposure in 43% of centres. 72% centres monitor metabolic bone health. Only 51% of units screen IBD patients for colorectal cancer, but screening is done with high-definition endoscopy in 92%. Chromoendoscopy with targeted biopsies is performed in only 47% units. Patients with perianal fistula are managed by combined medical and surgical approach in 67%, and reassessment by clinical and endoscopy and/or pelvic MRI is done in 62%. Laparoscopic approach for intra-abdominal surgery is used in 76%, and preoperative nutritional assessment in 62%. Patients receive therapies to prevent post-operative recurrence based on risk factors in 70%, standard endoscopy within 6-12 months after surgery is done only in 52% of centres. Although only 8% of centres lack a defined protocol to manage acute severe ulcerative colitis flares, 13% lack a standard algorithm, and 36% do not involve the surgeon in this setting from day 1. 38% of centres have a paediatric to adult transition clinic. The main reason for not adhering to ECCO standards are difficulty of providing tests in a timely fashion in up to 83% of centres. Our survey has revealed significant gaps between ECCO standards and real-world practice. These results will help ECCO improve initiatives to help institutions to provide standard QoC. 1) Fiorino et al. JCC 2020;14:1037-48
DOP03 ECCO护理质量标准与现实世界之间的差距:关于过程和结果的E-QUALITY调查
欧洲克罗恩病与结肠炎组织(ECCO)关于护理质量(QoC)的立场文件提出了管理炎症性肠病(IBD)患者的单位在流程和结果方面的基本标准。E-QUALITY 工作组调查了这些标准与实际操作之间是否存在差距。 我们制作了一份包含 74 个问题的网络调查问卷,ECCO 的所有附属机构均可参与。要求每个机构派一名代表回答。进行了描述性分析。 从 2023 年 3 月到 10 月,来自 28 个不同国家的 166 个中心对调查做出了回复(图 1)。在诊断时,96% 的人通过结肠镜评估疾病范围,43% 的人通过小肠 (SB) 评估完成诊断。55%的患者在每个肠段至少进行 2 次活检。60%的中心会对克罗恩病(CD)进行 SB 检查。54%的中心为大多数患者提供深度镇静的内窥镜检查。为了评估治疗反应,65% 的中心使用粪便钙蛋白,54% 的中心使用内窥镜,36% 的中心使用横断面 CD 成像。在任何药物治疗初次失败的情况下,98%的患者会根据炎症的客观指标做出治疗决定。42%的无症状患者按照计划进行监测。84%的中心将长期使用皮质类固醇的患者转为节省类固醇的治疗方法,但43%的中心没有制定跟踪或处理高类固醇暴露的方案。72%的中心对代谢性骨健康进行监测。只有 51% 的机构对 IBD 患者进行结直肠癌筛查,但 92% 的机构使用高清内窥镜进行筛查。只有 47% 的单位进行了带有目标活检的色谱内镜检查。67%的肛周瘘患者采用内外科联合治疗,62%的患者通过临床、内镜和/或盆腔磁共振成像进行重新评估。76%的患者采用腹腔镜方法进行腹腔内手术,62%的患者进行术前营养评估。70%的患者会根据风险因素接受预防术后复发的治疗,只有52%的中心会在术后6-12个月内进行标准内镜检查。虽然只有 8% 的中心缺乏管理急性重度溃疡性结肠炎复发的明确方案,但 13% 的中心缺乏标准算法,36% 的中心没有让外科医生从手术第一天起就参与其中。38%的中心设有儿科向成人过渡诊所。多达 83% 的中心不遵守 ECCO 标准的主要原因是难以及时提供测试。 我们的调查揭示了ECCO标准与实际操作之间的巨大差距。这些结果将有助于ECCO改进措施,帮助机构提供标准的质量控制。1) Fiorino 等人,JCC 2020;14:1037-48
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信